Illumina Sues Premaitha Health Over NIPT IP; Swiss Firm Adopts Premaitha's Iona CE-IVD Test

Mar 16, 2015

|

NEW YORK (GenomeWeb) – Illumina and its wholly-owned subsidiary Verinata Health have filed a patent infringement suit against Premaitha Health over IP relating to non-invasive prenatal testing, the companies said today.

The suit, filed in the High Court of Justice, Chancery Division, Patents Court in the UK, asserts European Patent (UK) 0 994 963 B2 and European Patent (UK) 1 981 995 B1, both relating to the use of cell-free fetal DNA for NIPT.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Hope, But Cost Worries

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

Cleared the Committee

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

One Gene to Shape the Face

One gene regulates hundreds of others to influence facial development, according to New Scientist.

Nature Studies Review Resources for Single-Cell Analysis, Examine ALS Exomes, More

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.

Menu

Illumina Sues Premaitha Health Over NIPT IP; Swiss Firm Adopts Premaitha's Iona CE-IVD Test

To read the full story....

Breaking News

Veritas Genetics Halts US Operations

New Products Posted to GenomeWeb: Quadrant Biosciences, InterVenn Biosciences, Macrogen, More

Childhood Kidney Cancer Arises From Altered Normal Tissue, Sequencing Study Finds

Amgen Gifts $1M to Keck Graduate Institute for Genomics Education Center

Ancestors of Sub-Saharan Africans Interbred With Archaic Humans

Centogene Q3 Revenues Decrease 13 Percent Due to Non-Recurring Payments From Pharma Partners

The Scan

Hope, But Cost Worries

Cleared the Committee

One Gene to Shape the Face

Nature Studies Review Resources for Single-Cell Analysis, Examine ALS Exomes, More

What's Popular?

Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Illumina, PacBio Dispute UK Regulator's Finding That Merger Would Weaken Competition

Ambry Genetics, Caris Life Sciences Partner on Cancer Genetic Testing

Veracyte Exclusively Licenses NanoString Diagnostic Platform for Up to $60M

Centogene Q3 Revenues Decrease 13 Percent Due to Non-Recurring Payments From Pharma Partners

Sponsorships